HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG

Advanced heart treatment from Beacon care team helps patient feel like himself again > Beacon Health System

Dolan Maraouche When Dolan Maraouche was told during a routine colonoscopy that he had an irregular heart rhythm, he was skeptical. After all, he had never noticed any symptoms. He even joked with his gastroenterologist, saying, “Stick to what you know!” Still, Dolan followed up with his primary care provider, who referred him to Beacon Medical Group Advanced Cardiovascular Specialists RiverPointe. There, he learned that he had been in Afib — wh…

HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG

HeartBeam Inc. (NASDAQ: BEAT) has announced groundbreaking results from its VALID-ECG pivotal study, showcasing the high diagnostic accuracy of its synthesized 12-lead ECG technology. The study, which compared HeartBeam’s compact device against standard ECGs, found a 93.4% diagnostic agreement for arrhythmia assessment, a critical milestone for the company’s FDA submission. Presented by Dr. Thomas Deering of the Piedmont Heart Institute at the H…